• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cortex Pharmaceuticals Inc

+ Add to Watchlist


0.038 EUR 0.0000.00%

As of 02:16:08 ET on 12/23/2014.

Snapshot for Cortex Pharmaceuticals Inc (PHX)

Open: 0.038 Day's Range: 0.038 - 0.038 Volume: 0
Previous Close: 0.038 52wk Range: 0.020 - 0.063 1-Yr Rtn: +52.00%

Stock Chart for PHX

No chart data available.
  • PHX:GR 0.038
  • 1D
  • 1M
  • 1Y
Interactive PHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 5.47
Shares Outstanding (M) 144.04
30 Day Average Volume 67
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHX

No data available

Company Profile & Key Executives for PHX

Cortex Pharmaceuticals, Inc. discovers, develops, and commercializes pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. The Company develops a family of chemical compounds, known as Ampakines, that enhance the activity of the AMPA-type glutamate receptor.

Mark A VarneyPresident/CEORobert N WeingartenVP/CFO
More Company Profile & Key Executives for PHX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil